Clinical Trials Logo

Clinical Trial Summary

To measure the impact of a coaching program on the patient's health-related quality of life 15 months post-transplant (M15/R12).


Clinical Trial Description

After signing the consent form and validating the inclusion and non-inclusion criteria, patients will be included in the study. They will be randomized unequally (2:1) into one of the study groups: - OC (Onco-Coaching) group: patients will undergo onco-coaching sessions at a rate of 1 session/month until 6 months post-inclusion (M9/R6). 73 patients will be randomized in this group - Group C (Control): Patients will not receive onco-coaching follow-up, but will be able to benefit from classical management in full autonomy. 35 patients will be randomized in this group ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05486273
Study type Interventional
Source Institut Paoli-Calmettes
Contact Dominique GENRE, Dr
Phone 0491223778
Email drci.up@ipc.unicancer.fr
Status Not yet recruiting
Phase N/A
Start date January 2, 2023
Completion date January 2, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT03056469 - Patient-Reported Outcomes Integrated in the Follow-up of Patients With Hematological Cancer N/A
Completed NCT01524445 - Retrospective Survey of Re-treatment With Bortezomib Phase 4
Recruiting NCT03218254 - MethylphenIdate for Fatigue in Haematological Cancer Phase 3
Recruiting NCT05099237 - Enhanced Monitoring for Better Recovery and Cancer Experience in Greater Manchester N/A